Medicover AB (publ) provides healthcare and diagnostic services in Poland, Germany, Romania, India, Sweden, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $19.30 | N/A |
Market Cap | $1.41B | N/A |
Shares Outstanding | 72.98M | N/A |
Employees | 44.00K | N/A |